Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 3/20 | 0.71 |
| ▸ | AKR1C3 | P42330 | 4/20 | 0.64 |
| ▸ | AKR1C2 | P52895 | 3/20 | 0.64 |
| ▸ | TTR | P02766 | 2/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.64 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 6/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.58 |
| ▸ | DHODH | Q02127 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18109767 | 0.91 | FABP4 (0.85) | FABP4AKR1C3AKR1C2TTRPTGS1 | |
| SCHEMBL7841736 | 0.87 | FABP4 (0.85) | FABP4AKR1C3AKR1C2TTRPTGS1 | |
| Fenamic Acid SCHEMBL25828 | 0.87 | FABP4 (0.92) | FABP4AKR1C3AKR1C2TTRPTGS1 | |
| Fenamic Acid SCHEMBL29622832 | 0.87 | FABP4 (0.92) | FABP4AKR1C3AKR1C2TTRPTGS1 | |
| Fenamic Acid SCHEMBL3657701 | 0.85 | FABP4 (0.89) | FABP4AKR1C3AKR1C2TTRPTGS1 | |
| Fenamic Acid SCHEMBL28520019 | 0.85 | FABP4 (0.89) | FABP4AKR1C3AKR1C2TTRPTGS1 | |
| Fenamic Acid SCHEMBL10800939 | 0.85 | FABP4 (0.89) | FABP4AKR1C3AKR1C2TTRPTGS1 | |
| Fenamic Acid SCHEMBL27758639 | 0.85 | FABP4 (0.89) | FABP4AKR1C3AKR1C2TTRPTGS1 | |
| Fenamic Acid SCHEMBL11800213 | 0.85 | FABP4 (0.89) | FABP4AKR1C3AKR1C2TTRPTGS1 | |
| Fenamic Acid SCHEMBL27646881 | 0.85 | FABP4 (0.89) | FABP4AKR1C3AKR1C2TTRPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090131527-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-05-21 | — | — | US | claimed |
| US-4921875-A | Use of amino-substituted benzoic acids as remedies for diarrhea, and medicaments based on these compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-05-01 | — | — | US | claimed |
| US-20230381133-A1 | TAU AND AMYLOID PROTEIN LOWERING COMPOUNDS AND METHODS OF USE | HAMAD BIN KHALIFA UNIVERSITY (QA) | 2023-11-30 | — | — | US | disclosed |
| US-20230381133-A1 | TAU AND AMYLOID PROTEIN LOWERING COMPOUNDS AND METHODS OF USE | HAMAD BIN KHALIFA UNIVERSITY (QA) | 2023-11-30 | — | — | US | disclosed |
| US-20230381133-A1 | TAU AND AMYLOID PROTEIN LOWERING COMPOUNDS AND METHODS OF USE | HAMAD BIN KHALIFA UNIVERSITY (QA) | 2023-11-30 | — | — | US | disclosed |
| CN-114585681-A | Thermoplastic elastomer composition | 陶氏环球技术有限责任公司 | 2022-06-03 | — | — | CN | disclosed |
| EP-3764416-B1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO LTD (KR) | 2022-01-26 | — | — | EP | disclosed |
| US-20210013420-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2021-01-14 | — | — | US | disclosed |
| CN-105764883-B | Thermoplastic polymer composition | 美利肯公司 | 2019-06-04 | — | — | CN | disclosed |
| CN-105764883-A | Thermoplastic polymer composition | 美利肯公司 | 2016-07-13 | — | — | CN | disclosed |
| CN-105764971-A | Thermoplastic polymer composition | 美利肯公司 | 2016-07-13 | — | — | CN | disclosed |
| CN-105745264-A | Thermoplastic polymer composition | 美利肯公司 | 2016-07-06 | — | — | CN | disclosed |
| CN-105745189-A | Thermoplastic polymer composition | 美利肯公司 | 2016-07-06 | — | — | CN | disclosed |
| US-20150051286-A1 | ANTHRANILIC ACID DERIVATIVES: NOVEL INHIBITORS OF ADVANCED GLYCATION END-PRODUCTS (AGES) FORMATION | CHOUDHARY MUHAMMAD IQBAL (PK) | 2015-02-19 | — | — | US | disclosed |
| US-20150051286-A1 | ANTHRANILIC ACID DERIVATIVES: NOVEL INHIBITORS OF ADVANCED GLYCATION END-PRODUCTS (AGES) FORMATION | CHOUDHARY MUHAMMAD IQBAL (PK) | 2015-02-19 | — | — | US | disclosed |
| US-20090131527-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-05-21 | — | — | US | disclosed |
| US-20060241108-A1 | Substituted phenoxazines and acridones as inhibitors of AKT | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2006-10-26 | — | — | US | disclosed |
| WO-2006094207-A2 | SUBSTITUTED PHENOXAZINES AND ACRIDONES AS INHIBITORS OF AKT | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2006-09-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210013420-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, OR10J3 | FABP4 2297/4885AKR1C3 4381/4885AKR1C2 4062/4885 |
| US-20150051286-A1 | ANTHRANILIC ACID DERIVATIVES: NOVEL INHIBITORS OF ADVANCED GLYCATION END-PRODUCTS (AGES) FORMATION | AGER, NFKBIA, DNPEP | FABP4 228/4885AKR1C3 978/4885AKR1C2 734/4885 |
| US-20090131527-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME | CLIC1, ASIC1, CLIC4 | FABP4 1600/4885AKR1C3 787/4885AKR1C2 477/4885 |
| US-20230381133-A1 | TAU AND AMYLOID PROTEIN LOWERING COMPOUNDS AND METHODS OF USE | MAPT, TTR, HTT | FABP4 1130/4885AKR1C3 3315/4885AKR1C2 3216/4885 |
| US-20060241108-A1 | Substituted phenoxazines and acridones as inhibitors of AKT | AKT1S1, AKT3, PIK3CA | FABP4 2313/4885AKR1C3 1303/4885AKR1C2 1345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.